JP2019527228A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019527228A5 JP2019527228A5 JP2019503748A JP2019503748A JP2019527228A5 JP 2019527228 A5 JP2019527228 A5 JP 2019527228A5 JP 2019503748 A JP2019503748 A JP 2019503748A JP 2019503748 A JP2019503748 A JP 2019503748A JP 2019527228 A5 JP2019527228 A5 JP 2019527228A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- hydrogen
- alkyl group
- base
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1613054.4A GB201613054D0 (en) | 2016-07-28 | 2016-07-28 | New compound and process |
| GB1613054.4 | 2016-07-28 | ||
| PCT/GB2017/052190 WO2018020249A1 (en) | 2016-07-28 | 2017-07-27 | New compound and process |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019527228A JP2019527228A (ja) | 2019-09-26 |
| JP2019527228A5 true JP2019527228A5 (https=) | 2021-06-17 |
| JP6985367B2 JP6985367B2 (ja) | 2021-12-22 |
Family
ID=56936838
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019503748A Active JP6985367B2 (ja) | 2016-07-28 | 2017-07-27 | 新規化合物および方法 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US10710998B2 (https=) |
| EP (1) | EP3490988B1 (https=) |
| JP (1) | JP6985367B2 (https=) |
| KR (1) | KR102396059B1 (https=) |
| CN (1) | CN109641891B (https=) |
| CY (1) | CY1122138T1 (https=) |
| DK (1) | DK3490988T3 (https=) |
| ES (1) | ES2751948T3 (https=) |
| GB (1) | GB201613054D0 (https=) |
| HR (1) | HRP20192109T1 (https=) |
| HU (1) | HUE046509T2 (https=) |
| LT (1) | LT3490988T (https=) |
| PL (1) | PL3490988T3 (https=) |
| PT (1) | PT3490988T (https=) |
| RS (1) | RS59566B1 (https=) |
| SI (1) | SI3490988T1 (https=) |
| SM (1) | SMT201900582T1 (https=) |
| TW (1) | TWI739871B (https=) |
| WO (1) | WO2018020249A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3142701T3 (en) | 2014-05-12 | 2018-08-13 | Verona Pharma Plc | New treatment |
| GB201502260D0 (en) | 2015-02-11 | 2015-04-01 | Verona Pharma Plc | Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound |
| PT4090654T (pt) * | 2020-01-17 | 2025-10-07 | Lupin Ltd | Métodos, processos e intermediários para a preparação de compostos de cromano |
| CN116917287A (zh) | 2021-04-29 | 2023-10-20 | 苏州盛迪亚生物医药有限公司 | 异喹啉酮类化合物及其用途 |
| JP2024545189A (ja) * | 2021-12-14 | 2024-12-05 | シーツァン ハイスコ ファーマスーティカル カンパニー リミテッド | 三環式縮合複素環系ｐｄｅ３／４二重阻害剤及びその用途 |
| GB202202297D0 (en) | 2022-02-21 | 2022-04-06 | Verona Pharma Plc | Formulation production process |
| EP4378942A1 (en) | 2022-12-02 | 2024-06-05 | Sandoz AG | Crystal form of a pde3/4 inhibitor |
| WO2025003643A1 (en) | 2023-06-26 | 2025-01-02 | Verona Pharma Plc | Particulate composition comprising ensifetrine |
| CN121620356A (zh) | 2023-06-26 | 2026-03-06 | 维罗纳制药公司 | 包含恩塞芬汀的颗粒组合物 |
| US20250073240A1 (en) | 2023-09-06 | 2025-03-06 | Verona Pharma Plc | New treatment |
| US20250249007A1 (en) | 2024-02-07 | 2025-08-07 | Verona Pharma Plc | Pharmaceutical compositions of ensifentrine for chronic obstructive pulmonary disease |
| WO2025168708A1 (en) | 2024-02-07 | 2025-08-14 | Verona Pharma Plc | Pharmaceutical compositions of ensifentrine for chronic obstructive pulmonary disease |
| WO2025176871A1 (en) | 2024-02-23 | 2025-08-28 | Inke, S.A. | Process for preparing pyrimido[6,1-a]isoquinoline-4-ones |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ185900A (en) | 1976-12-10 | 1981-04-24 | Hoechst Ag | Pyrimido (6,1-a) isoquinolin-4-ones medicaments intermediate isoquinolines |
| FI64370C (fi) | 1977-05-05 | 1983-11-10 | Hoechst Ag | Foerfarande foer framstaellning av terapeutiskt anvaendbara pyimido-(6,1-a)isokinolin-2-imino-4-onderivat |
| DE2847693A1 (de) | 1978-11-03 | 1980-05-22 | Hoechst Ag | Verfahren zur herstellung von pyrimido-(6,1-a)-isochinolin-2-onen |
| DE3135831A1 (de) | 1981-09-10 | 1983-04-28 | Hoechst Ag, 6230 Frankfurt | 9,10-substituierte 2-mesitylimino-3-alkyl-3,4,6,7-tetrahydro-2h-pyrimido(6,1-a)isochinolin-4-one, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| CA1237429A (en) | 1983-05-05 | 1988-05-31 | Frank Kienzle | Pyrimidone derivatives |
| ES2208310T3 (es) | 1999-03-31 | 2004-06-16 | Vernalis Limited | Derivados de pirimido(6,1-a) isoquinolin-4-ona. |
| PH12013500261A1 (en) | 2010-08-09 | 2013-03-04 | Verona Pharma Plc | Crystalline form of pyrimidio[6,1-a]isoquinolin-4-one compound |
| EP2968313B1 (en) | 2013-03-15 | 2018-01-31 | Verona Pharma PLC | Drug combination |
| DK3142701T3 (en) | 2014-05-12 | 2018-08-13 | Verona Pharma Plc | New treatment |
| CN110051627A (zh) | 2014-09-15 | 2019-07-26 | 维罗纳制药公司 | 包含rpl554的液体吸入制剂 |
| GB201502260D0 (en) | 2015-02-11 | 2015-04-01 | Verona Pharma Plc | Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound |
-
2016
- 2016-07-28 GB GBGB1613054.4A patent/GB201613054D0/en not_active Ceased
-
2017
- 2017-07-27 PT PT177488806T patent/PT3490988T/pt unknown
- 2017-07-27 WO PCT/GB2017/052190 patent/WO2018020249A1/en not_active Ceased
- 2017-07-27 HU HUE17748880A patent/HUE046509T2/hu unknown
- 2017-07-27 DK DK17748880T patent/DK3490988T3/da active
- 2017-07-27 TW TW106125312A patent/TWI739871B/zh active
- 2017-07-27 EP EP17748880.6A patent/EP3490988B1/en active Active
- 2017-07-27 LT LTEP17748880.6T patent/LT3490988T/lt unknown
- 2017-07-27 SI SI201730098T patent/SI3490988T1/sl unknown
- 2017-07-27 PL PL17748880T patent/PL3490988T3/pl unknown
- 2017-07-27 RS RS20191474A patent/RS59566B1/sr unknown
- 2017-07-27 US US16/309,435 patent/US10710998B2/en active Active
- 2017-07-27 SM SM20190582T patent/SMT201900582T1/it unknown
- 2017-07-27 ES ES17748880T patent/ES2751948T3/es active Active
- 2017-07-27 HR HRP20192109TT patent/HRP20192109T1/hr unknown
- 2017-07-27 CN CN201780046788.1A patent/CN109641891B/zh active Active
- 2017-07-27 JP JP2019503748A patent/JP6985367B2/ja active Active
- 2017-07-27 KR KR1020197004436A patent/KR102396059B1/ko active Active
-
2019
- 2019-10-04 CY CY20191101046T patent/CY1122138T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019527228A5 (https=) | ||
| JP7440989B2 (ja) | ２－［５－（３－クロロフェニル）－３－ヒドロキシピリジン－２－カルボニル］アミノ］酢酸を調製するための方法 | |
| JP6633539B2 (ja) | ２−（２，４−ジフルオロフェニル）−１，１−ジフルオロ−１−（５−置換−ピリジン−２−イル）−３−（１ｈ−テトラゾール−１−イル）プロパン−２−オールおよびその調製工程 | |
| KR102586087B1 (ko) | 다이아릴티오하이단토인 화합물의 제조 방법 | |
| RU2014137470A (ru) | Способы и соединения, которые можно использовать для синтеза антагонистов рецепторов орексина-2 | |
| HRP20192109T1 (hr) | Novi spoj i proces | |
| JP6954456B2 (ja) | スルファミン酸リチウムの製造方法及び新規スルファミン酸リチウム | |
| CA3070070A1 (en) | Intermediates useful for the synthesis of a selective inhibitor against protein kinase and processes for preparing the same | |
| TW201713616A (zh) | 製造雙胍鹽及ｓ-三之方法 | |
| JP2014511387A5 (https=) | ||
| KR20230135109A (ko) | 3-(2-클로로티아졸-5-일)-8-메틸-7-옥소-6-페닐-2,3-디히드로티아졸로[3,2-a]피리미딘-4-이움-5-올레이트의거울상이성질체 풍부 형태의 제조 방법 | |
| JP2021504505A5 (https=) | ||
| JP2019521165A5 (https=) | ||
| JP2013527149A5 (https=) | ||
| JP2024056922A (ja) | ジアミノピリミジン誘導体またはその酸付加塩の新規な製造方法 | |
| JP7349551B2 (ja) | 含フッ素ピリミジン化合物およびその製造方法 | |
| JP2022153486A (ja) | 殺有害生物化合物の調製方法 | |
| JP2010024173A (ja) | ９−アミノシンコナアルカロイドの製造法 | |
| WO2021193685A1 (ja) | 含フッ素ピリミジン化合物およびその製造方法 | |
| RU2854030C1 (ru) | Способ получения энантиомерно обогащенной формы 3-(2-хлортиазол-5-ил)-8-метил-7-оксо-6-фенил-2,3-дигидротиазоло[3,2-a]пиримидин-4-ий-5-олата | |
| TWI915494B (zh) | 製備富含鏡像異構型態的3-(2-氯噻唑-5-基)-8-甲基-7-氧代-6-苯基-2,3-二氫噻唑并[3,2-a]嘧啶-4-鎓-5-醇鹽的方法 | |
| WO2021085540A1 (ja) | 含フッ素ピリミジン化合物およびその製造方法 | |
| CN106854125B (zh) | 一种制备含有两个手性中心α-氟-β-乙炔基酮化合物的方法 | |
| JP7097363B2 (ja) | 殺有害生物化合物の調製方法 | |
| JP2018531907A5 (https=) |